AstraZeneca says its COVID shot has market potential despite lower demand
Reuters, 29 Apr 2022
AstraZeneca's COVID-19 vaccine still has market potential despite an expected global oversupply of shots and delays in the vaccine's approval in the United States, its chief executive Pascal Soriot said on Friday.
#AstraZeneca #COVID #Vaccine #News #Reuters
Subscribe: http://smarturl.it/reuterssubscribe
Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled.
Get the latest news on: http://reuters.com/
Follow Reuters on Facebook: https://www.facebook.com/Reuters
Follow Reuters on Twitter: https://twitter.com/Reuters
Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en